Mustgrow Biologics Corp Stock Analysis
| MGRO Stock | 0.75 0.01 1.35% |
MustGrow Biologics Corp is overvalued with Real Value of 0.7 and Hype Value of 0.72. The main objective of MustGrow Biologics stock analysis is to determine its intrinsic value, which is an estimate of what MustGrow Biologics Corp is worth, separate from its market price. There are two main types of MustGrow Biologics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect MustGrow Biologics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of MustGrow Biologics' stock to identify patterns and trends that may indicate its future price movements.
The MustGrow Biologics stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. MustGrow Biologics is usually not traded on New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day. MustGrow Stock trading window is adjusted to America/Toronto timezone.
MustGrow |
MustGrow Stock Analysis Notes
The company recorded a loss per share of 0.01. MustGrow Biologics Corp had not issued any dividends in recent years. To find out more about MustGrow Biologics Corp contact the company at 306-668-2652 or learn more at https://mustgrow.ca.MustGrow Biologics Corp Investment Alerts
| MustGrow Biologics generated a negative expected return over the last 90 days | |
| MustGrow Biologics has some characteristics of a very speculative penny stock | |
| MustGrow Biologics has high historical volatility and very poor performance | |
| MustGrow Biologics has high likelihood to experience some financial distress in the next 2 years |
MustGrow Largest EPS Surprises
Earnings surprises can significantly impact MustGrow Biologics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-04-27 | 2023-03-31 | -0.03 | -0.02 | 0.01 | 33 | ||
2022-11-29 | 2022-09-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2022-08-26 | 2022-06-30 | -0.02 | -0.03 | -0.01 | 50 |
MustGrow Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 38.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MustGrow Biologics's market, we take the total number of its shares issued and multiply it by MustGrow Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.MustGrow Profitablity
MustGrow Biologics' profitability indicators refer to fundamental financial ratios that showcase MustGrow Biologics' ability to generate income relative to its revenue or operating costs. If, let's say, MustGrow Biologics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, MustGrow Biologics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of MustGrow Biologics' profitability requires more research than a typical breakdown of MustGrow Biologics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.10) | (0.10) | |
| Return On Capital Employed | (0.10) | (0.11) | |
| Return On Assets | (0.10) | (0.10) | |
| Return On Equity | (0.12) | (0.12) |
Management Efficiency
MustGrow Biologics Corp has return on total asset (ROA) of (0.0151) % which means that it has lost $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1477) %, meaning that it generated substantial loss on money invested by shareholders. MustGrow Biologics' management efficiency ratios could be used to measure how well MustGrow Biologics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.1 in 2024. Return On Capital Employed is likely to drop to -0.11 in 2024. Asset Turnover is likely to climb to 0.71 in 2024, whereas Return On Tangible Assets are likely to drop (0.10) in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.11 | 0.06 | |
| Tangible Book Value Per Share | 0.11 | 0.06 | |
| Enterprise Value Over EBITDA | (98.26) | (103.17) | |
| Price Book Value Ratio | 11.53 | 12.10 | |
| Enterprise Value Multiple | (98.26) | (103.17) | |
| Price Fair Value | 11.53 | 12.10 | |
| Enterprise Value | 58.3 M | 55.4 M |
The analysis of MustGrow Biologics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze MustGrow Biologics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of MustGrow Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin (0.03) | Profit Margin (0.14) | Beta 1.666 | Return On Assets (0.02) | Return On Equity (0.15) |
Technical Drivers
As of the 29th of June, MustGrow Biologics secures the Risk Adjusted Performance of (0.10), standard deviation of 3.61, and Mean Deviation of 2.72. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MustGrow Biologics Corp, as well as the relationship between them. Please verify MustGrow Biologics Corp coefficient of variation, variance, and the relationship between the mean deviation and standard deviation to decide if MustGrow Biologics Corp is priced some-what accurately, providing market reflects its recent price of 0.75 per share.MustGrow Biologics Corp Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MustGrow Biologics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MustGrow Biologics Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
MustGrow Biologics Predictive Daily Indicators
MustGrow Biologics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MustGrow Biologics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
MustGrow Biologics Forecast Models
MustGrow Biologics' time-series forecasting models are one of many MustGrow Biologics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MustGrow Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About MustGrow Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MustGrow Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MustGrow shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MustGrow Biologics. By using and applying MustGrow Stock analysis, traders can create a robust methodology for identifying MustGrow entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.14) | (0.15) | |
| Operating Profit Margin | (0.13) | (0.13) | |
| Net Loss | (0.14) | (0.15) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MustGrow Biologics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Additional Tools for MustGrow Stock Analysis
When running MustGrow Biologics' price analysis, check to measure MustGrow Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MustGrow Biologics is operating at the current time. Most of MustGrow Biologics' value examination focuses on studying past and present price action to predict the probability of MustGrow Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MustGrow Biologics' price. Additionally, you may evaluate how the addition of MustGrow Biologics to your portfolios can decrease your overall portfolio volatility.